SELVAAG BOLIG And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – SELVAAG BOLIG (SBO.OL), VERALLIA (VRLA.PA), VOSS VEKSEL OGLAND (VVL.OL) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. SELVAAG BOLIG (SBO.OL)

132.6% sales growth and 10.32% return on equity

Selvaag Bolig ASA, a housing development company, engages in the development, construction, and sale of residential properties in Greater Oslo, Bergen, Stavanger, Trondheim, and Stockholm. The company also offers project management services. Selvaag Bolig ASA was incorporated in 2008 and is headquartered in Oslo, Norway. Selvaag Bolig ASA is a subsidiary of Selvaag AS.

Earnings Per Share

As for profitability, SELVAAG BOLIG has a trailing twelve months EPS of kr2.58.

PE Ratio

SELVAAG BOLIG has a trailing twelve months price to earnings ratio of 11.32. Meaning, the purchaser of the share is investing kr11.32 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.32%.

Sales Growth

SELVAAG BOLIG’s sales growth is negative 52.8% for the current quarter and 132.6% for the next.

More news about SELVAAG BOLIG.

2. VERALLIA (VRLA.PA)

19.7% sales growth and 44.03% return on equity

Verallia Société Anonyme produces and sells glass packaging products for beverages and food industry worldwide. It also provides bottles for still and sparkling wines, spirits, beers, soft drinks, and oils. The company offers jars for baby food, dairy products, jams, honey, spreads, condiments, sauces, and preserves. Verallia Société Anonyme was founded in 1827 and is based in Courbevoie, France.

Earnings Per Share

As for profitability, VERALLIA has a trailing twelve months EPS of €4.08.

PE Ratio

VERALLIA has a trailing twelve months price to earnings ratio of 10.29. Meaning, the purchaser of the share is investing €10.29 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 44.03%.

Sales Growth

VERALLIA’s sales growth is 27.9% for the current quarter and 19.7% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 30.7%, now sitting on 3.86B for the twelve trailing months.

Volume

Today’s last reported volume for VERALLIA is 94506 which is 27.08% below its average volume of 129609.

More news about VERALLIA.

3. VOSS VEKSEL OGLAND (VVL.OL)

16% sales growth and 9.14% return on equity

Voss Veksel- og Landmandsbank ASA provides banking products and services to private individuals and companies in Norway. The company offers saving accounts; car and other vehicle, home, small, and construction loans; overdrafts facilities; leasing services; bank guarantees; bank and payment cards; insurance products; and online and mobile banking services. The company was founded in 1843 and is based in Voss, Norway.

Earnings Per Share

As for profitability, VOSS VEKSEL OGLAND has a trailing twelve months EPS of kr26.35.

PE Ratio

VOSS VEKSEL OGLAND has a trailing twelve months price to earnings ratio of 8.58. Meaning, the purchaser of the share is investing kr8.58 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.14%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 44.9%, now sitting on 141.48M for the twelve trailing months.

Yearly Top and Bottom Value

VOSS VEKSEL OGLAND’s stock is valued at kr226.00 at 12:20 EST, way under its 52-week high of kr252.00 and way higher than its 52-week low of kr190.00.

More news about VOSS VEKSEL OGLAND.

4. BOUVET (BOUV.OL)

9.7% sales growth and 60.9% return on equity

Bouvet ASA provides IT and digital communication consultancy services for public and private sector companies in Norway, Sweden, and internationally. Bouvet ASA was founded in 1995 and is based in Oslo, Norway.

Earnings Per Share

As for profitability, BOUVET has a trailing twelve months EPS of kr3.09.

PE Ratio

BOUVET has a trailing twelve months price to earnings ratio of 18.51. Meaning, the purchaser of the share is investing kr18.51 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 60.9%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 16.5%, now sitting on 3.22B for the twelve trailing months.

Volume

Today’s last reported volume for BOUVET is 40135 which is 14.98% above its average volume of 34905.

More news about BOUVET.

5. VISTIN PHARMA (VISTN.OL)

6.6% sales growth and 5.32% return on equity

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr0.3.

PE Ratio

VISTIN PHARMA has a trailing twelve months price to earnings ratio of 76.67. Meaning, the purchaser of the share is investing kr76.67 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.32%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

VISTIN PHARMA’s EBITDA is 2.36.

Revenue Growth

Year-on-year quarterly revenue growth grew by 54.7%, now sitting on 410.31M for the twelve trailing months.

Moving Average

VISTIN PHARMA’s worth is higher than its 50-day moving average of kr22.73 and way higher than its 200-day moving average of kr19.49.

More news about VISTIN PHARMA.

6. SPAREBANKEN MØRE (MORG.OL)

6.5% sales growth and 11.3% return on equity

Sparebanken Møre, together with its subsidiaries, provides banking services for retail and corporate customers in Norway. It operates through Retail and Real Estate Brokerage segments. The company offers services in the areas of financing, deposits and other forms of investments, payment transfers, financial advisory services, asset management, insurance, and real estate brokerage. Sparebanken Møre was founded in 1843 and is headquartered in Ålesund, Norway.

Earnings Per Share

As for profitability, SPAREBANKEN MØRE has a trailing twelve months EPS of kr16.2.

PE Ratio

SPAREBANKEN MØRE has a trailing twelve months price to earnings ratio of 4.69. Meaning, the purchaser of the share is investing kr4.69 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.3%.

More news about SPAREBANKEN MØRE.

Leave a Reply

Your email address will not be published. Required fields are marked *